PERFUSION MEDICAL, INC.

Federal contract awards won by PERFUSION MEDICAL, INC. (UEI XEDJGXP1K889), 2023–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

4
awards
1
expiring in 12 months
1
agency

Category award history

4 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: INNOFLIGHT, LLC took Department of Defense 541715 work from PERFUSION MEDICAL, INC. (May 18, 2026).

Agencies buying from PERFUSION MEDICAL, INC.

Department of Defense (4)

What PERFUSION MEDICAL, INC. has provided

541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (4)

Awards

IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC
Department of Defense · $1,499,773 · Apr 10, 2026
HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG
Department of Defense · $1,799,970 · Jun 24, 2024
RESEARCH AND DEVELOPMENT OF OPTIMAL DOSING AND FORMULATION OF PM-208 (PEG-20K/8K) FOR AF FIELD USE
Department of Defense · $1,799,322 · Feb 9, 2024
DHA SBIR DIRECT TO PHASE II MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2D-0122 FOR "IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC"
Department of Defense · $2,986,773 · Sep 15, 2023